S&P Global Ratings upgraded India's growth projection for the current financial year on domestic momentum but lowered its outlook for the next financial year citing subdued global growth and base effect.
Abeona Therapeutics Inc. (ABEO) announced the FDA has accepted and granted Priority Review for the Biologics License Application for pz-cel, the company's investigational autologous, COL7A1 gene-corrected epidermal sheets for the treatment of patients with recessive dystrophic epidermolysis bullosa.
Euro area price growth outlook continued to be surround by significant uncertainty and it is not yet time to declare the end of the fight against inflation, European Central Bank President Christine Lagarde said Monday.
Euro area price growth outlook continued to be surround by significant uncertainty and it is not yet time to declare the end of the fight against inflation, European Central Bank President Christine Lagarde said Monday.
Biopharmaceutical company 89bio, Inc. (ETNB) announced Monday positive topline data from the blinded extension phase of its Phase 2b ENLIVEN trial evaluating treatment with pegozafermin in patients with nonalcoholic steatohepatitis (NASH).